4.8 Article

Chromatin Prepattern and Histone Modifiers in a Fate Choice for Liver and Pancreas

Journal

SCIENCE
Volume 332, Issue 6032, Pages 963-966

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1202845

Keywords

-

Funding

  1. FAMRI Foundation
  2. NIH [U54MH084691, RO1 GM067718, R37GM36477, U01DK072503]
  3. Acylin Therapeutics

Ask authors/readers for more resources

Transcriptionally silent genes can be marked by histone modifications and regulatory proteins that indicate the genes' potential to be activated. Such marks have been identified in pluripotent cells, but it is unknown how such marks occur in descendant, multipotent embryonic cells that have restricted cell fate choices. We isolated mouse embryonic endoderm cells and assessed histone modifications at regulatory elements of silent genes that are activated upon liver or pancreas fate choices. We found that the liver and pancreas elements have distinct chromatin patterns. Furthermore, the histone acetyltransferase P300, recruited via bone morphogenetic protein signaling, and the histone methyltransferase Ezh2 have modulatory roles in the fate choice. These studies reveal a functional prepattern of chromatin states within multipotent progenitors and potential targets to modulate cell fate induction.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available